These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29535627)

  • 1. Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer.
    Liu G; Claret FX; Zhou F; Pan Y
    Front Pharmacol; 2018; 9():135. PubMed ID: 29535627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jab1/Cops5: a promising target for cancer diagnosis and therapy.
    Yuan C; Wang D; Liu G; Pan Y
    Int J Clin Oncol; 2021 Jul; 26(7):1159-1169. PubMed ID: 34019195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients.
    Hou J; Liu G; Yuan Y; Wang D; Jiao P; Xing L; Pan Y
    Oncotarget; 2017 Nov; 8(57):97504-97515. PubMed ID: 29228627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer analyses of Jab1/COPS5 reveal oncogenic role and clinical outcome in human cancer.
    Wang L; Zeng X; Yang G; Liu G; Pan Y
    Heliyon; 2022 Dec; 8(12):e12553. PubMed ID: 36643321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer.
    Danielpour D; Purighalla S; Wang E; Zmina PM; Sarkar A; Zhou G
    Biochem Biophys Res Commun; 2019 Oct; 518(2):374-380. PubMed ID: 31434609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
    Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging roles of Jab1/CSN5 in cancer.
    Wang L; Zheng JN; Pei DS
    Med Oncol; 2016 Aug; 33(8):90. PubMed ID: 27412572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcription co-factor JAB1/COPS5, serves as a potential oncogenic hub of human chondrosarcoma cells
    Mamidi MK; Samsa WE; Danielpour D; Chan R; Zhou G
    Am J Cancer Res; 2021; 11(10):5063-5075. PubMed ID: 34765312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Let-7d Inhibits Growth and Metastasis in Breast Cancer by Targeting Jab1/Cops5.
    Wei Y; Liu G; Wu B; Yuan Y; Pan Y
    Cell Physiol Biochem; 2018; 47(5):2126-2135. PubMed ID: 29975923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jab1/Cops5 contributes to chemoresistance in breast cancer by regulating Rad51.
    Liu G; Yu M; Wu B; Guo S; Huang X; Zhou F; Claret FX; Pan Y
    Cell Signal; 2019 Jan; 53():39-48. PubMed ID: 30244171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAB1/CSN5: a new player in cell cycle control and cancer.
    Shackleford TJ; Claret FX
    Cell Div; 2010 Oct; 5():26. PubMed ID: 20955608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5.
    Wu B; Pan Y; Liu G; Yang T; Jin Y; Zhou F; Wei Y
    Front Oncol; 2019; 9():1170. PubMed ID: 31788446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jab1/Csn5-Thioredoxin Signaling in Relapsed Acute Monocytic Leukemia under Oxidative Stress.
    Zhou F; Pan Y; Wei Y; Zhang R; Bai G; Shen Q; Meng S; Le XF; Andreeff M; Claret FX
    Clin Cancer Res; 2017 Aug; 23(15):4450-4461. PubMed ID: 28270496
    [No Abstract]   [Full Text] [Related]  

  • 14. Cops5 safeguards genomic stability of embryonic stem cells through regulating cellular metabolism and DNA repair.
    Li P; Gao L; Cui T; Zhang W; Zhao Z; Chen L
    Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2519-2525. PubMed ID: 31964807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
    Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
    Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Jab1 expression inhibits proliferation and promotes apoptosis of AMC-HN-8 cells.
    Li PH; Wang L; Pan YJ; Sang MM; Zheng JN; Pei DS
    Oncol Lett; 2018 Apr; 15(4):5137-5142. PubMed ID: 29552148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.
    Pan Y; Wang S; Su B; Zhou F; Zhang R; Xu T; Zhang R; Leventaki V; Drakos E; Liu W; Claret FX
    Oncogene; 2017 Feb; 36(8):1069-1079. PubMed ID: 27524414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR.
    Lu R; Hu X; Zhou J; Sun J; Zhu AZ; Xu X; Zheng H; Gao X; Wang X; Jin H; Zhu P; Guo L
    Nat Commun; 2016 Jul; 7():12044. PubMed ID: 27375289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of differential gene expression profile identifies novel biomarkers for breast cancer.
    Pan Y; Liu G; Yuan Y; Zhao J; Yang Y; Li Y
    Oncotarget; 2017 Dec; 8(70):114613-114625. PubMed ID: 29383106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M
    Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.